Archford Capital Strategies’s ResMed RMD Stock Holding History

Archford Capital Strategies’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-910	Closed	-$204K	–	372
2026 Q1	$204K	Sell	910 -158	-15%	-$39.4K	0.02%	329
2025 Q4	$257K	Sell	1,068 -76	-7%	-$19.4K	0.03%	301
2025 Q3	$313K	Sell	1,144 -118	-9%	-$32.2K	0.04%	267
2025 Q2	$326K	Buy	+1,262	New	+$301K	0.04%	261
2024 Q4	–	Sell	-872	Closed	-$210K	–	269
2024 Q3	$210K	Buy	+872	New	+$195K	0.03%	246
2022 Q2	–	Sell	-867	Closed	-$213K	–	290
2022 Q1	$213K	Buy	+867	New	+$210K	0.05%	267
2021 Q4	–	Sell	-867	Closed	-$228K	–	312
2021 Q3	$228K	Hold	867	–	–	0.05%	288
2021 Q2	$214K	Buy	+867	New	+$182K	0.05%	287
2014 Q4	–	Sell	-38	Closed	-$2K	–	759
2014 Q3	$2K	Sell	38 -20	-34%	-$1.02K	﹤0.01%	526
2014 Q2	$2.94K	Buy	+58	New	+$2.88K	﹤0.01%	593

Other funds holding RMD

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return

Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

CISOA

Capital Investment Services of America Milwaukee, Wisconsin $1.02B AUM 3.04% 1-Year Est. Return

DJSG

D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Archford Capital Strategies's RMD Position: Q2 2026 in Review

Archford Capital Strategies sold out of ResMed (RMD) in Q2 2026, closing a stake of 910 shares — an estimated $204K sold.

Archford Capital Strategies first reported a position in RMD in Q2 2014 and held it in 10 quarters. The position peaked at $326K in Q2 2025. 196 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Archford Capital Strategies reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
Archford Capital Strategies sold 910 ResMed shares in Q2 2026, an estimated $204K.
Archford Capital Strategies first reported a position in ResMed in Q2 2014 and held it in 10 quarters.
Archford Capital Strategies's ResMed position peaked at $326K in Q2 2025.
196 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Archford Capital Strategies's 13F filing for Q2 2026, filed 17 Jul 2026.